The G20 Global Pharma Summit Series-Canada is a significant event that brings together key stakeholders in the pharmaceutical industry. A critical topic of discussion at the summit is Pharmacovigilance and Drug Safety Monitoring.
Pharmacovigilance is the science and activities related to the detection, assessment, understanding, and prevention of adverse effects or any other drug-related problems. It plays a crucial role in ensuring that medicines on the market are safe and effective for their intended use.
Drug Safety Monitoring, on the other hand, is a continuous process that begins with the discovery of a new drug and continues throughout the product's entire market life. It involves the collection, analysis, monitoring, and prevention of adverse effects in drugs.
At the G20 Global Pharma Summit, these topics are discussed in depth, with a focus on improving global health outcomes and ensuring the safety and efficacy of pharmaceutical products.